Results 251 to 260 of about 822,039 (299)
Antibody–drug conjugates (ADCs) transform breast cancer therapy, yet resistance limits their durability. Emerging evidence reveals that ADC failure is not solely tumor‐intrinsic but shaped by dynamic tumor–microenvironment interactions that alter drug delivery, processing, and response.
Minji Seo, Jangsoon Lee, Naoto T. Ueno
wiley +1 more source
A healthy gut barrier shields underlying fibroblasts from luminal shear forces, illustrating that “good fences make good neighbors.” Barrier damage exposes fibroblasts to shear stress, inducing cell death and the emergence of stress‐adapted, profibrotic fibroblasts. Sustained shear exposure promotes the formation of stiff aggregates of mechanoadapative
Soyoun Min +6 more
wiley +1 more source
Targeting the PDK1/c‐Myc/SOX10 Signaling in Oligodendrocytes Alleviates Neuropathic Pain
This work reveals that oligodendrocyte homeostasis, mediated by PDK1, is a critical determinant of neuropathic pain (NPP) pathogenesis. Disruption of PDK1 in oligodendrocytes impairs SOX10‐dependent myelination programs through c‐Myc accumulation, leading to disrupted myelination and the pathophysiology of NPP.
Pingping Qiao +7 more
wiley +1 more source
This study identifies an immunometabolic axis wherein SAM‐driven PRMT1 methylates LDHA, enhancing its activity. The resultant lactate induces STAT3 K709 lactylation, which stabilizes an active conformation to promote STAT3 phosphorylation and IL‐10 expression.
Hui Wang +12 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Chest, 2000
The anti-inflammatory cytokines are a series of immunoregulatory molecules that control the proinflammatory cytokine response. Cytokines act in concert with specific cytokine inhibitors and soluble cytokine receptors to regulate the human immune response.
Steven M Opal
exaly +3 more sources
The anti-inflammatory cytokines are a series of immunoregulatory molecules that control the proinflammatory cytokine response. Cytokines act in concert with specific cytokine inhibitors and soluble cytokine receptors to regulate the human immune response.
Steven M Opal
exaly +3 more sources
Anti-inflammatory cytokines in sickle cell disease
Molecular Biology Reports, 2022Sickle cell disease (SCD) is a well-studied monogenetic disease with an established chronic inflammatory component. The paradigm shift towards inflammation has made the pathophysiology of SCD even more complex. Studies have shown that an imbalance between the pro-inflammatory and anti-inflammatory cytokines in SCD exists; however, the reports are ...
Adekunle E Alagbe +2 more
exaly +3 more sources
Anti-inflammatory Cytokines and Cytokine Antagonists
Current Pharmaceutical Design, 2000Cytokines are critical mediators of protective host responses, including defense against microbial invasion and tumorigenesis. However, the production of specific proinflammatory cytokines must be tightly regulated and compartmentalized to prevent the overzealous expression of these molecules that can culminate in unabated inflammation and tissue ...
openaire +2 more sources
G-CSF - an anti-inflammatory cytokine-
Shock, 1995We have previously reported that in various macrophage populations prepared from G-CSF treated rats LPS-inducible TNF release was suppressed. In vitro, LPS induced liver cell death only when hepatocytes were cocultured with liver macrophages.
T. Hartung, H-D. Volk, A. Wendel
openaire +1 more source
Activin as an anti-inflammatory cytokine produced by microglia
Journal of Neuroimmunology, 2007The main objective of the present study was to determine if activin might inhibit microglial activation. In murine MG6 microglial cell cultures, lipopolysaccharide (LPS)-induced activation of these cells was mitigated by pretreatment with activin as assessed by compromised up-regulation of proinflammatory markers, including IL-18, IL-6 and iNOS.
Shuei, Sugama +4 more
openaire +2 more sources
Anti-Inflammatory Cytokines: Expression and Action in the Brain
Neuroimmunomodulation, 2001Transforming growth factor-β<sub>1</sub> (TGF-β<sub>1</sub>) and interleukin (IL)-10 gene expression is equivocal in normal brain and upregulated in over a dozen central and peripheral diseases/disorders. The patterns of specific expression of cytokines differ in these diseases.
L, Vitkovic, S, Maeda, E, Sternberg
openaire +2 more sources

